Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XR-NTX in Reward Drinkers with Alcohol Use Disorder
NCT05028062Phase 4Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Mar 2022
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in alcohol use disorder (AUD), sponsored by University of Pennsylvania. Started Mar 2022; status: recruiting.
02
Drugs
naltrexone
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05028062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05028062.